SEA-CD40 is a CD40 agonist with early evidence of pharmacodynamic and antitumor activity: Preliminary results from a phase I study in advanced solid malignancies

Authors
Category Primary study
ConferenceJournal for ImmunoTherapy of Cancer
Year 2016
This article has no abstract
Epistemonikos ID: 8e1dcf8ac608044144632ce8024a2ad6ac5be89e
First added on: Apr 29, 2026